High-density hematoma

High-density hematoma predicts atorvastatin efficacy in humans.

“high-density hematoma, basal cistern compression, and hematoma volume to be independent risk factors for the efficacy of atorvastatin monotherapy in patients with moderate CSDH.”

Humansmoderate chronic subdural hematoma receiving atorvastatin monotherapy24 weeksn = 89

Risk Factors for Atorvastatin as a Monotherapy for Chronic Subdural Hematoma: A Retrospective Multifactor Analysis

Frontiers in aging neuroscience·1 Sep 2021